IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Sanofi-Aventis Acquires Pfizer’s Insulin Facility in Germany

10:37 AM MDT | June 12, 2009 | DEEPTI RAMESH

Sanofi-Aventis (Paris) says it has acquired one of the world’s largest insulin plants at Frankfurt, Germany, from Pfizer for €30 million. Sanofi-Aventis aims to strengthen its insulin production capacities with the acquisition. The deal includes buildings, equipment, machinery, and some existing contracts, Sanofi-Aventis says. The transaction is expected to close in the next few weeks. “The strong increase in demand for our insulins, especially Lantus, drives us to considerably extend our production capacities,” says Martin Siewert, general...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa